Format

Send to

Choose Destination
Z Rheumatol. 2005 Sep;64(6):416-22.

[Bone morphogenetic proteins in the skeletal system].

[Article in German]

Author information

1
Zentrum Innere Medizin, Abteilung Nephrologie und Rheumatologie, Universitätsklinikum der Georg-August-Universität Göttingen, Robert-Koch-Strasse 40, 37075 Göttingen, Germany. c.bramlage@med.uni-goettingen.de

Abstract

Bone morphogenetic proteins (BMPs) belong to the transforming growth factor-beta superfamily. Their potential for organ and tissue regeneration and repair has been intensively investigated in recent years. Studies on fetal development have demonstrated the important role of these proteins for the development and differentiation of different organs. Miss-expression or mutation of BMPs may lead to severe abnormalities or even abortion. However, a regenerative potential has also been recognized for the adult organism. BMPs support fracture healing and may contribute to treatment of joint diseases. Thus, BMP-7 is one of the first BMPs approved for clinical application in non-unions of bone fractures resistant to conventional therapy. In degenerative and inflammatory joint diseases, experimental data suggest a decrease of BMP expression in cartilage tissue. Therefore, BMPs could be promising therapeutic candidates in these diseases, although more detailed analyses are necessary. In this review we will focus on bone morphogenetic proteins and discuss present and putative future clinical applications.

PMID:
16184350
DOI:
10.1007/s00393-005-0665-0
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center